These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36494704)

  • 21. Sex-Specific Regulation of β-Secretase: A Novel Estrogen Response Element (ERE)-Dependent Mechanism in Alzheimer's Disease.
    Cui J; Ait-Ghezala G; Sambamurti K; Gao F; Shen Y; Li R
    J Neurosci; 2022 Feb; 42(6):1154-1165. PubMed ID: 34903570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of 11C-labeled naphthalene derivative as a novel non-peptidergic probe for the β-secretase (BACE1) imaging in Alzheimer's disease brain.
    Kawai T; Kawashima H; Kuge Y; Saji H
    Nucl Med Biol; 2013 Jul; 40(5):705-9. PubMed ID: 23706549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer's disease via BACE1-mediated APP processing.
    Wang Y; Cui Y; Liu J; Song Q; Cao M; Hou Y; Zhang X; Wang P
    Alzheimers Res Ther; 2022 Jul; 14(1):103. PubMed ID: 35883144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated long-term forgetting is a BACE1 inhibitor-reversible incipient cognitive phenotype in Alzheimer's disease model mice.
    Ohno M
    Neuropsychopharmacol Rep; 2021 Jun; 41(2):255-259. PubMed ID: 33749160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BACE1-Specific DNA Aptamer A1 Rescues Amyloid-β Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease.
    Liang ZM; Peng YH; Chen Y; Long LL; Luo HJ; Chen YJ; Liang YL; Tian YH; Li SJ; Shi YS; Zhang XM
    Nucleic Acid Ther; 2019 Dec; 29(6):359-366. PubMed ID: 31513457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's Disease and β-secretase Inhibition: An Update with a Focus on Computer-aided Inhibitor Design.
    Ugbaja SC; Lawal IA; Kumalo HM; Lawal MM
    Curr Drug Targets; 2022; 23(3):266-285. PubMed ID: 34370634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
    Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
    Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
    J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer's disease.
    Pradeepkiran JA; Reddy AP; Yin X; Manczak M; Reddy PH
    Hum Mol Genet; 2020 Jan; 29(1):49-69. PubMed ID: 31595293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
    Devi L; Tang J; Ohno M
    Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.
    Velliquette RA; O'Connor T; Vassar R
    J Neurosci; 2005 Nov; 25(47):10874-83. PubMed ID: 16306400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase.
    Buggia-Prévot V; Fernandez CG; Riordan S; Vetrivel KS; Roseman J; Waters J; Bindokas VP; Vassar R; Thinakaran G
    Mol Neurodegener; 2014 Jan; 9():1. PubMed ID: 24386896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease.
    Ewers M; Cheng X; Zhong Z; Nural HF; Walsh C; Meindl T; Teipel SJ; Buerger K; He P; Shen Y; Hampel H
    J Alzheimers Dis; 2011; 25(2):373-81. PubMed ID: 21460439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-186 is decreased in aged brain and suppresses BACE1 expression.
    Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
    J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains.
    Harada H; Tamaoka A; Ishii K; Shoji S; Kametaka S; Kametani F; Saito Y; Murayama S
    Neurosci Res; 2006 Jan; 54(1):24-9. PubMed ID: 16290302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.